Nabors Louis Burt,...,Grujicic Danica M,...,(broj koautora 17) (2015) Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study, NEURO-ONCOLOGY, vol. 17, br. 5, str. 708-717 (Article)